Cystatin C- and creatinine-based equations in the assessment of renal function in HIV-positive patients prior to commencing Highly Active Antiretroviral Therapy

Annals of Clinical Biochemistry

Volumn 53, Issue 1, 2016, Pages 58-66

  Seape, Tebogo ^a   Gounden, Verena ^a,b   van Deventer, Hendrick E ^a,c   Candy, Geoffrey P ^d   George, Jaya A ^a  

^a NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c LANCET LABORATORIES   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

cystatin C; Estimated glomerular filtration rate; HIV; modification of diet in renal disease; prediction equations

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CREATININE; CYSTATIN C; EDETATE CHROMIUM CR 51;

ADULT; AFRICAN AMERICAN; ARTICLE; CALCULATION; CHRONIC KIDNEY DISEASE EPIDEMIOLOGY COLLABORATION EQUATION; COCKCROFT GAULT EQUATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; MODIFICATION OF DIET IN RENAL DISEASE EQUATION; PLASMA CLEARANCE; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; BLOOD; HIV INFECTIONS; PATHOPHYSIOLOGY; PROCEDURES; STANDARD; STANDARDS;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CREATININE; CROSS-SECTIONAL STUDIES; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HUMANS; KIDNEY FUNCTION TESTS; MALE; REFERENCE STANDARDS;

EID: 84950327093     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563215579695     Document Type: Article

References (53)

1. UNAIDS. The Joint United Nations Programme on HIV/AIDS. UNAIDS/WHO AIDS Epidemic Update, December 2007
2. A.MocroftS.VellaT.L.Benfield. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet1998; 352: 1725–1730.
3. E.VittinghoffS.ScheerP.O’Malley. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. J Infect Dis1999; 179: 717–720.
4. R.M.SelikR.H.ByersJrM.S.Dworkin. Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987–1999. J Acquir Immune Defic Syndr2002; 29: 378–387.
5. J.A.WinstonG.C.BurnsP.E.Klotman. The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy. Semin Nephrol1998; 18: 373–377.
6. A.I.ChoiR.A.RodriguezP.Bacchetti. The impact of HIV on chronic kidney disease outcomes. Kidney Int2007; 72: 1380–1387.
7. T.E.GerntholtzS.J.GoetschI.Katz. HIV-related nephropathy: a South African perspective. Kidney Int2006; 69: 1885–1891.
8. N.WearneC.R.SwanepoelA.Boulle. The spectrum of renal histologies seen in HIV with outcomes, prognostic indicators and clinical correlations. Nephrol Dial Transplant2012; 27: 4109–4118.
9. E.J.SchwartzL.A.SzczechM.J.Ross. Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. J Am Soc Nephrol2005; 16: 2412–2420.
10. P.J.PetersD.M.MooreJ.Mermin. Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int2008; 74: 925–929.
11. D.VerhelstM.MongeJ.L.Meynard. Fanconi syndrome and renal failure induced by tenofovir: a first case report. Am J Kidney Dis2002; 40: 1331–1333.
12. K.K.Wools-KaloustianS.K.Gupta. Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell. Kidney Int2008; 74: 845–847.
13. E.K.SumailiE.P.CohenC.V.Zinga. High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo. BMC Nephrol2009; 10: 18–18.
14. J.BandaA.MweembaS.Siziya. Prevalence and factors associated with renal dysfunction in HIV positive and negative adults at the University Teaching Hospital, in Lusaka. Med J Zambia2010; 37: 136–142.
15. K.Wools-KaloustianS.K.GuptaE.Muloma. Renal disease in an antiretroviral-naive HIV-infected outpatient population in Western Kenya. Nephrol Dial Transplant2007; 22: 2208–2212.
16. L.B.MulengaG.KruseS.Lakhi. Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia. AIDS2008; 22: 1821–1827.
17. A.S.LeveyJ.P.BoschJ.B.Lewis. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med1999; 130: 461–470.
18. D.W.CockcroftM.H.Gault. Prediction of creatinine clearance from serum creatinine. Nephron1976; 16: 31–41.
19. A.S.LeveyL.A.StevensC.H.Schmid. A new equation to estimate glomerular filtration rate. Ann Intern Med2009; 150: 604–612.
20. L.A.InkerC.H.SchmidH.Tighiouart. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med2012; 367: 20–29.
21. H.A.ChapmanJrJ.J.ReillyJrR.Yee. Identification of cystatin C, a cysteine proteinase inhibitor, as a major secretory product of human alveolar macrophages in vitro. Am Rev Respir Dis1990; 141: 698–705.
22. A.GrubbO.SimonsenG.Sturfelt. Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand1985; 218: 499–503.
23. G.FillerA.BokenkampW.Hofmann. Cystatin C as a marker of GFR–history, indications, and future research. Clin Biochem2005; 38: 1–8.
24. H.E.van DeventerJ.E.PaikerI.J.Katz. A comparison of cystatin C- and creatinine-based prediction equations for the estimation of glomerular filtration rate in black South Africans. Nephrol Dialy Transplant2011; 26: 1553–1558.
25. J.S.FlemingM.A.ZivanovicG.M.Blake. Guidelines for the measurement of glomerular filtration rate using plasma sampling. Nucl Med Commun2004; 25: 759–769.
26. J.Brochner-Mortensen. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest1972; 30: 271–274.
27. D.Du BoisE.F.Du Bois. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med1916; 17: 863–871.
28. G.L.MyersW.G.MillerJ.Coresh. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem2006; 52: 5–18.
29. A.S.LeveyJ.CoreshT.Greene. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem2007; 53: 766–772.
30. H.E.van DeventerJ.A.GeorgeJ.E.Paiker. Estimating glomerular filtration rate in black South Africans by use of the modification of diet in renal disease and Cockcroft-Gault equations. Clin Chem2008; 54: 1197–1202.
31. X.GuoY.QinK.Zheng. Improved glomerular filtration rate estimation using new equations combined with standardized cystatin C and creatinine in Chinese adult chronic kidney disease patients. Clin Biochem2014; 47: 1220–1226.
32. K.PraditpornsilpaA.AvihingsanonT.Chaiwatanarat. Comparisons between validated estimated glomerular filtration rate equations and isotopic glomerular filtration rate in HIV patients. AIDS2012; 26: 1781–1788.
33. T.H.DriverR.ScherzerC.A.Peralta. Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women. AIDS2013; 27: 2291–2299.
34. World Health Organization (WHO). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, 2013
35. E.D.PoggioX.WangT.Greene. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol2005; 16: 459–466.
36. Wyatt CM, Schwartz GJ, Owino Ong’or W, et al. Estimating kidney function in HIV-infected adults in Kenya: comparison to a direct measure of glomerular filtration rate by iohexol clearance. PLoS One 2013; 8: e69601
37. L.A.StevensJ.CoreshT.Greene. Assessing kidney function – measured and estimated glomerular filtration rate. N Engl J Med2006; 354: 2473–2483.
38. A.EarleyD.MiskulinE.J.Lamb. Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med2012; 156: 785–795. W-270, W-1, W-2, W-3, W-4, W-5, W-6, W-7, W-8.
39. J.SalomonT.P.DeJ.C.Melchior. Nutrition and HIV infection. Br J Nutr2002; 87: S111–119.
40. C.S.AndradeR.P.JesusT.B.Andrade. Prevalence and characteristics associated with malnutrition at hospitalization among patients with acquired immunodeficiency syndrome in Brazil. PLoS One2012; 7: e48717–e48717.
41. N.D.MadalaN.NkwanyanaT.Dubula. Predictive performance of eGFR equations in South Africans of African and Indian ancestry compared with (9)mTc-DTPA imaging. Int Urol Nephrol2012; 44: 847–855.
42. L.A.StevensC.H.SchmidT.Greene. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int2009; 75: 652–660.
43. G.HarmanA.AkbariS.Hiremath. Accuracy of cystatin C-based estimates of glomerular filtration rate in kidney transplant recipients: a systematic review. Nephrol Dial Transplant2013; 28: 741–757.
44. L.A.InkerC.WyattR.Creamer. Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals. J Acquir Immune Defic Syndr2012; 61: 302–309.
45. K.PraditpornsilpaA.AvihingsanonT.Chaiwatanarat. Comparisons between validated estimated glomerular filtration rate equations and isotopic glomerular filtration rate in HIV patients. AIDS2012; 26: 1781–1788.
46. S.JoseL.HamzahL.J.Campbell. Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposure. J Infect Dis2014; 210: 363–373.
47. J.CoreshE.SelvinL.A.Stevens. Prevalence of chronic kidney disease in the United States. JAMA2007; 298: 2038–2047.
48. K.McCulloughP.SharmaT.Ali. Measuring the population burden of chronic kidney disease: a systematic literature review of the estimated prevalence of impaired kidney function. Nephrol Dial Transplant2012; 27: 1812–1821.
49. J.W.StaniferB.JingS.Tolan. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health2014; 2: e174–e181.
50. P.DelanayeE.P.Cohen. Formula-based estimates of the GFR: equations variable and uncertain. Nephron Clin Pract2008; 110: c48–53. discussion c4.
51. P.DelanayeE.CavalierA.Saint-Remy. Discrepancies between creatinine-based and cystatin C-based equations in estimating prevalence of stage 3 chronic kidney disease in an elderly population. Scand J Clin Lab Invest2009; 69: 344–349.
52. P.DelanayeE.CavalierO.Moranne. Creatinine-or cystatin C-based equations to estimate glomerular filtration in the general population: impact on the epidemiology of chronic kidney disease. BMC Nephrol2013; 14: 57–57.
53. P.DelanayeE.CavalierC.Mariat. MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant?BMC Nephrol2010; 11: 8–8.